Ashley Ross, MD, PHD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Astellas
    Date added:
    Date updated:
    02/22/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Myovant
    Date added:
    Date updated:
    02/22/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bayer
    Date added:
    Date updated:
    02/22/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    TEMPUS
    Date added:
    Date updated:
    02/22/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Myraid
    Date added:
    Date updated:
    02/22/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Blue Earth
    Date added:
    Date updated:
    02/22/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Pfizer
    Date added:
    Date updated:
    02/22/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Janssen
    Date added:
    Date updated:
    02/22/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    GenomeDx Biosciences
    Date added:
    Date updated:
    02/22/2023
Return to PARP Inhibitors: Assessing the Clinical Trial Landscape Webcast (2021)